This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 50 mg vials of the drug Activase. The $6,953.88 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency that supports military healthcare programs. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare globally. The contract award was not designated as a set-aside.
Generated 3/5/25, 10:11 AM